No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Sunny Bay’s Innovative Extra-Large Weighted Heat Wrap For All-Natural Pain Relief Is Now Available On Amazon

Lavender-Infused Heat Wrap Option Also Reduces Stress with Aromatherapy

Editor: What To Know

  • manufacturer, and retailer of high-quality pain relief neck wraps and heating pads have introduced a unique weighted heat wrap for pain relief.
  • Wide, the extra-large size is a comfortable fit for anyone’s body, in any position.
  • Our new weighted heat wrap can be used in multiple ways, hot and cold, for immediate pain relief and deep muscle relaxation.

Sunny Bay, a leading U.S. manufacturer, and retailer of high-quality pain relief neck wraps and heating pads have introduced a unique weighted heat wrap for pain relief.

The non-electric pad delivers moist heat to soothe body aches and pain from injury, fatigue, and period cramps. Sunny Bay’s mission is to create the most useful and durable heating pads and neck wraps.

“We designed this product based on our customers’ feedback,” said Sam Wright, CEO of Sunny Bay. “In these difficult economic times, people want luxury products at a low cost. Our new weighted heat wrap can be used in multiple ways, hot and cold, for immediate pain relief and deep muscle relaxation. We’re also offering a lavender-infused version aimed at reducing stress with aromatherapy.”

Several features place Sunny Bay’s latest offering above other heating pads on the market:

  • At 29″ long and 9″ wide, the extra-large size is a comfortable fit for anyone’s body, in any position. It delivers pain relief wherever it is needed most, including the neck, shoulders, backs, arms, legs, and even hands.
  • Sunny Bay products hold heat longer than other non-electric thermal therapy packs.
  • The lavender-infused version utilizes only premium lavender buds.
  • The soft, machine-washable cover is made of high-quality T-shirt cotton.

“Thermal therapy is an incredibly easy, effective way for people to relieve pain, reduce tiredness and increase relaxation naturally,” said Wright. “Our newest product helps people care for themselves at home, at work, and while traveling with an affordable, sustainable solution.”  More here and here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy